rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-9
|
pubmed:abstractText |
A series of indenopyrazoles 8 and 9 were designed and synthesized as EGFR tyrosine kinase inhibitors by in silico high-throughput screening. Compounds 8b and 8d showed significant inhibition of A431 cell growth (GI50 = 0.062 and 0.057 microM, respectively). Compounds 8b and 9a showed inhibitory activity toward both EGFR and VEGFR-2 (KDR) tyrosine kinases, whereas 8d inhibited VEGFR-2 tyrosine kinase, exclusively.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1464-3405
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
285-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17983745-Binding Sites,
pubmed-meshheading:17983745-Cell Line, Tumor,
pubmed-meshheading:17983745-Combinatorial Chemistry Techniques,
pubmed-meshheading:17983745-Crystallography, X-Ray,
pubmed-meshheading:17983745-Drug Design,
pubmed-meshheading:17983745-Humans,
pubmed-meshheading:17983745-Kinetics,
pubmed-meshheading:17983745-Models, Molecular,
pubmed-meshheading:17983745-Protein Kinase Inhibitors,
pubmed-meshheading:17983745-Pyrazoles,
pubmed-meshheading:17983745-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17983745-Structure-Activity Relationship,
pubmed-meshheading:17983745-Substrate Specificity,
pubmed-meshheading:17983745-Vascular Endothelial Growth Factor Receptor-2
|
pubmed:year |
2008
|
pubmed:articleTitle |
Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
|
pubmed:affiliation |
Department of Chemistry, Faculty of Science, Gakushuin University, Tokyo 171-8588, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|